Picture of Quantum Helium logo

QHE Quantum Helium News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapNeutral

REG - Quantum Helium Ltd - £5 Million Institutional Placing

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260417:nRSQ9157Aa&default-theme=true

RNS Number : 9157A  Quantum Helium Limited  17 April 2026

 

 

17 April 2026

 

Quantum Helium Limited

("Quantum" or the "Company")

 

 

£5 Million Institutional Placing Positions Quantum for Next Phase of Growth

Quantum Helium Limited (AIM: QHE) is pleased to announce it has today raised
£5 million (before expenses) by way of a conditional placing of
16,666,666,667 new ordinary shares (the "Placing Shares") at a price of 0.03
pence per share (the "Placing Price") (the "Placing").

The Placing was arranged by OAK Securities and was undertaken with a number of
institutional investors who approached the Company, reflecting growing
interest in Quantum's asset base and the strategic importance of domestic US
helium supply.

Highlights

·      £5 million institutional placing

·      Cornerstoned by institutional investors following inbound demand

·      Validates the strength of Quantum's helium portfolio and US
strategic positioning

·      Funding supports the next phase of development at Sagebrush and
Coyote Wash

·      Multiple near-term catalysts, including results from the
Company's extended production test at Sagebrush

·      Strengthened balance sheet and cash resources positions the
Company well for next phase of growth

Background to the Placing

The Company has received increasing inbound interest from institutional
investors in recent months, driven by the scale and quality of its helium
portfolio and the growing strategic importance of helium as a critical
commodity.

Helium plays an essential role in a wide range of high-value industries,
including semiconductor manufacturing, AI infrastructure, medical imaging and
advanced manufacturing, with demand continuing to increase.

At the same time, global helium supply remains constrained, with recent
geopolitical developments, including disruptions in the Middle East,
highlighting the importance of secure and domestic supply chains. This
backdrop has resulted in increased investor focus on US-based helium
development opportunities.

Quantum believes it is well positioned within this environment, with a
portfolio of helium assets located in a proven US helium fairway and a clear
pathway towards development and production.

Use of Funds

Proceeds from the Placing will be used to:

·      Advance development planning and engineering at the Sagebrush
Project

·      Progress permitting, planning and progressing to drill-ready
targets at Coyote Wash (100% owned)

·      Fund well planning, long-lead items and infrastructure design at
the Company's Sagebrush and Coyote Wash projects

·      Support ongoing technical work, including seismic interpretation
and subsurface modelling

·      Provide additional working capital and financial flexibility

The Company's extended production test at the Sagebrush-1 well which remains
the key near-term operational milestone is being funded from existing cash
resources.

Current Operations

As announced on 16 April 2026, the extended production test at the Sagebrush-1
well is progressing well, with operations advancing in line with expectations.

The next phase of operations will focus on the perforation and testing of the
first of two zones in the Leadville Formation. The Lower Leadville will be
tested first, followed by a test of the upper Leadville where the DST was
previously run. Perforations are scheduled to start this coming week.

The testing programme is designed to evaluate flow characteristics and confirm
historical helium concentrations, including the previously reported 2.76%
helium, and represents a critical step towards converting resources into
reserves and advancing towards commercial development.

The Company expects a number of significant operational updates in the coming
weeks as testing progresses through this key phase.

Carl Dumbrell, Chairman of Quantum Helium, said: "This is a very strong
outcome for the Company and we are pleased to have secured the support of a
number of high-quality institutional investors who recognised the strength of
our asset base and the opportunity we are developing.

The Placing reflects increasing awareness of the strategic importance of
helium, particularly in the United States, where there is a growing need for
secure and domestic supply. Recent global events have further highlighted
supply constraints, and we believe Quantum is well positioned to play a role
in addressing this.

Importantly, this funding places the Company in the strongest financial
position it has ever been in and allows us to accelerate our development plans
while maintaining momentum across our operations.

We look forward to delivering on the significant milestones ahead and
continuing to build value for shareholders."

Quantum Chief Executive, Howard McLaughlin, added: "As outlined in our recent
operational update, the extended production test program at Sagebrush-1 is
progressing well and represents a major step towards unlocking the commercial
potential of this project.

We are particularly excited about the upcoming perforation of the Lower
Leadville Formation, which is expected to provide critical data on helium
concentrations and flow rates. This will build on the historic results and
further strengthen our understanding of the reservoir.

With this successful placing, we are now fully funded to execute our broader
work programme across both Sagebrush and Coyote Wash. We have a number of
important and exciting milestones ahead and remain confident in the outcome of
the extended production test.

Our focus is firmly on progressing our projects towards commercialisation and
establishing Quantum as a leading helium developer in the United States.

Additional Information

Quantum Helium has appointed OAK Securities (a trading name of Merlin Partners
LLP), to act as the Company's exclusive bookrunner and placement agent in
connection with the Placing. Subject to and conditional on Admission, OAK
Securities will be paid an annual broker retainer of £50,000 payable in cash,
a one-off corporate advisory fee of £15,000 payable in cash, a cash
commission in an amount equal to six per cent (6.0%) of the gross proceeds
raised pursuant to the Placing.  The Company will also issue OAK Securities
warrants (the "Broker Warrants") to subscribe for 6.0% of the number of
Placing Shares placed in the Placing, with such Broker Warrants being
exercisable at a price per share equal to the Issue Price for 3 years from the
date of the closing of the Placing.

The Placing Shares, when issued and fully paid, will rank pari passu in all
respects with the existing Common Shares in issue and therefore will rank
equally for all dividends or other distributions declared, made or paid after
the issue of the new Placing Shares.

 

 

Admission to AIM and Total Voting Rights

The Placing is conditional, inter alia, upon the Placing Shares being admitted
to trading on AIM. Application has been made to the London Stock Exchange for
the Placing Shares, which will rank pari passu with the Company's existing
issued ordinary shares, to be admitted to trading on AIM and dealings are
expected to commence at 8:00 a.m. on or around 23 April 2026.

Following the issue of the Placing Shares, the Company's total voting rights
will comprise 49,985,396,722 Ordinary Shares of no par value, and the
Company does not hold any shares in treasury. The above figure may therefore
be used by shareholders as the denominator for the calculations by which they
will determine whether they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under the
Companies' Articles.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the
European Union (Withdrawal) Act 2018. Upon publication via Regulatory
Information Service ('RIS'), this information is now in the public domain

 

Enquiries:

 Quantum Helium Limited     NOMAD and Joint Broker

 Carl Dumbrell              SP Angel Corporate Finance LLP

 Chairman                   Stuart Gledhill / Richard Hail / Adam Cowl

                            +44 (0) 20 3470 0470
 Brand Communications       Joint Broker

 Alan Green                 CMC Markets UK Plc

 Tel: +44 (0) 7976 431608   Douglas Crippen

                            +44 (0) 020 3003 8632

                            Joint Broker

                            OAK Securities

                            Jerry Keen / Robert Bell

                            Tel: +44 (0) 203 973 3678

 

Updates on the Company's activities are regularly posted on its website:
www.quantum-helium.com

 

Notes to editors

Quantum (AIM: QHE) is a helium and hydrocarbon exploration, development, and
production company with projects in the US and Australia. Quantum's strategic
objectives remain consistent: to identify opportunities which will provide
operating cash flow and have development upside, in conjunction with
progressing exploration. The Company has several projects in the US, in
addition to royalty interests in Australia.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEIRMATMTTBMFF



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Quantum Helium

See all news